Displaying 3401 - 3420 of 4742
FTC Staff Says Proposed Connecticut Legislation Would Likely Increase Health Care Costs and Decrease Access to Care
Hikma Pharmaceuticals PLC, In the Matter of (Baxter)
The Commission required Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire Baxter’s entire generic injectable pharmaceutical business for $111.5 million, including Baxter’s Cherry Hill, New Jersey, manufacturing facility and a warehouse and distribution center in Memphis, Tennessee. Phenytoin is an anti-convulsant drug used to control and prevent seizures during or after surgery and Promethazine is used to prevent some types of allergies or allergic reactions, to prevent or control motion sickness, nausea, vomiting, and dizziness, and to help patients go to sleep and control their pain or anxiety before or after surgery.
FTC Staff Submits Comment to FERC on Assessing the Effects of Proposed Horizontal Mergers on Market Power
FTC Approves Universal Health Services' and Psychiatric Solutions' Application to Sell the Delaware Behavioral Health Assets
FTC Approves Final Order Settling Charges that Hikma Pharmaceuticals PLC's Acquisition of Baxter Healthcare Assets was Anticompetitive
FTC Issues Agenda for Workshop to Explore the Role of Patented Technology in Collaborative Industry Standards
FTC Seeks Public Comment on Universal Health Services' Application to Sell Las Vegas Psychiatric Facilities
FTC Staff Comment Before the Federal Energy Regulatory Commission Concerning Analysis of Horizontal Market Power under the Federal Power Act (Docket No. RM11-14-000)
FTC Challenges Grifols/Talecris Merger as Anticompetitive
FTC Conditions Irving Oil's Proposed Acquisition of ExxonMobil Assets in Maine
FTC Files Amicus Brief in U.S. Court of Appeals for the Third Circuit in K-Dur Antitrust Litigation Urging Reversal of Pay-for-Delay Ruling
International Competition Network Presents Vision for its Second Decade
FTC Staff Says Proposed Massachusetts Law Would Limit Competition and Raise Costs in Distribution of Malt Beverages
FTC Chairman Leibowitz, Commissioner Kovacic to Participate in 10th Annual International Competition Network Conference In The Hague, The Netherlands
FTC Settlement Order Bars Texas Doctors' Group from Joint Price Negotiations
FTC Staff Finds Sanofi-Aventis, Watson Pharmaceuticals, and Synthon Holding B.V. Failed to Report Drug Patent Agreements as Required by Law
Another Dose of Competition: Accountable Care Organizations and Antitrust
FTC to Host Public Forum on Competition Issues in Standard-Setting
FTC Approves Dow Chemical Application to Amend Agreement with Huntsman Related to Union Carbide Acquisition
Displaying 3401 - 3420 of 4742